BAFF BINDING INHIBITOR HAVING 4-(2-BENZYLIDENE HYDRAZINYL)-2-PHENYLPYRIMIDINE DERIVATIVE AS ACTIVE INGREDIENT

摘要

PROBLEM TO BE SOLVED: To provide a drug which inhibits the BAFF binding to a BR3 receptor and has excellent preventing and treating effects on autoimmune diseases, acquired immunodeficiency syndrome, and non-Hodgkin lymphoma.

SOLUTION: The BAFF binding inhibitor to a BR3 receptor includes a compound represented by formula (1) (wherein R1is a 1-10C alkyl group; and R2, R3, R4, and R5may be the same as or different from one another and are each hydrogen or a hydroxyl group), a salt thereof or a solvate thereof as an active ingredient.

COPYRIGHT: (C)2012,JPO&INPIT